SS
QNTM

SBI Securities’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

SBI Securities’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286 Buy
79
+4
+5% +$19 ﹤0.01% 3212
2026
Q1 		$362 Buy
75
+20
+36% +$90 ﹤0.01% 3012
2025
Q4 		$402 Sell
55
-100
-65% -$1.09K ﹤0.01% 2952
2025
Q3 		$2.54K Hold
155
– – ﹤0.01% 2330
2025
Q2 		$3.14K Sell
155
-2
-1% -$25 ﹤0.01% 2200
2025
Q1 		$1.21K Buy
157
+57
+57% +$328 ﹤0.01% 2502
2024
Q4 		$368 Buy
+100
New +$471 ﹤0.01% 3008

Other funds holding QNTM

PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SBI Securities's QNTM Position: Q2 2026 in Review

SBI Securities increased its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) stake by 5.3% in Q2 2026, buying an estimated $19 and bringing the position to 79 shares worth $286. The position accounts for ﹤0.01% of the portfolio, ranked #3212.

SBI Securities first reported a position in QNTM in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.14K in Q2 2025. 8 funds tracked by Wall St. Rank hold QNTM as of Q2 2026.

  • SBI Securities held 79 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $286 as of Q2 2026.
  • SBI Securities bought 4 Quantum Biopharma Class B Subordinate Voting Shares shares in Q2 2026, an estimated $19.
  • Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3212 holding.
  • SBI Securities first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $3.14K in Q2 2025.
  • 8 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.